Cancer Research Donn Young  Genetics and Biology of Brain Cancer
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Li, A. G.
Right arrow Articles by Wang, X.-J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Li, A. G.
Right arrow Articles by Wang, X.-J.
[Cancer Research 64, 7836-7845, November 1, 2004]
© 2004 American Association for Cancer Research


Regular Articles

Smad3 Knockout Mice Exhibit a Resistance to Skin Chemical Carcinogenesis

Allen G. Li1,2,3, Shi-Long Lu1,2,3, Ming-Xiang Zhang1,2,3, Chuxia Deng4 and Xiao-Jing Wang1,2,3

Departments of 1 Otolaryngology, 2 Dermatology, and 3 Cell and Developmental Biology, Oregon Health and Science University, Portland, Oregon; and 4 Mammalian Genetics Section, Genetics of Development and Disease Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland

It has been shown that Smad3 exerts both tumor-suppressive and -promoting roles. To evaluate the role of Smad3 in skin carcinogenesis in vivo, we applied a chemical skin carcinogenesis protocol to Smad3 knockout mice (Smad3–/– and Smad3+/–) and wild-type littermates (Smad3+/+). Smad3–/– mice exhibited reduced papilloma formation in comparison with Smad3+/+ mice and did not develop any squamous cell carcinomas. Further analysis revealed that Smad3 knockout mice were resistant to 12-O-tetradecanoylphorbol-13-acetate (TPA)–induced epidermal hyperproliferation. Concurrently, increased apoptosis was observed in TPA-treated Smad3–/– skin and papillomas when compared with those of wild-type mice. Expression levels of activator protein-1 family members (c-jun, junB, junD, and c-fos) and transforming growth factor (TGF)-{alpha} were significantly lower in TPA-treated Smad3–/– skin, cultured keratinocytes, and papillomas, as compared with Smad3+/+ controls. Smad3–/– papillomas also exhibited reduced leukocyte infiltration, particularly a reduction of tumor-associated macrophage infiltration, in comparison with Smad3+/+ papillomas. All of these molecular and cellular alterations also occurred to a lesser extent in Smad3+/– mice as compared with Smad3+/+ mice, suggesting a Smad3 gene dosage effect. Given that TGF-ß1 is a well-documented TPA-responsive gene and also has a potent chemotactic effect on macrophages, our study suggests that Smad3 may be required for TPA-mediated tumor promotion through inducing TGF-ß1–responsive genes, which are required for tumor promotion, and through mediating TGF-ß1–induced macrophage infiltration.




This article has been cited by other articles:


Home page
J. Cell Sci.Home page
V. L. Martins, J. J. Vyas, M. Chen, K. Purdie, C. A. Mein, A. P. South, A. Storey, J. A. McGrath, and E. A. O'Toole
Increased invasive behaviour in cutaneous squamous cell carcinoma with loss of basement-membrane type VII collagen
J. Cell Sci., June 1, 2009; 122(11): 1788 - 1799.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. Gratchev, J. Kzhyshkowska, S. Kannookadan, M. Ochsenreiter, A. Popova, X. Yu, S. Mamidi, E. Stonehouse-Usselmann, I. Muller-Molinet, L. Gooi, et al.
Activation of a TGF-{beta}-Specific Multistep Gene Expression Program in Mature Macrophages Requires Glucocorticoid-Mediated Surface Expression of TGF-{beta} Receptor II
J. Immunol., May 15, 2008; 180(10): 6553 - 6565.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
A. B. Glick, R. Perez-Lorenzo, and J. Mohammed
Context-dependent regulation of cutaneous immunological responses by TGF{beta}1 and its role in skin carcinogenesis
Carcinogenesis, January 1, 2008; 29(1): 9 - 14.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
S. Dennler, J. Andre, I. Alexaki, A. Li, T. Magnaldo, P. ten Dijke, X.-J. Wang, F. Verrecchia, and A. Mauviel
Induction of Sonic Hedgehog Mediators by Transforming Growth Factor-{beta}: Smad3-Dependent Activation of Gli2 and Gli1 Expression In vitro and In vivo
Cancer Res., July 15, 2007; 67(14): 6981 - 6986.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
A. J. Galliher and W. P. Schiemann
Src Phosphorylates Tyr284 in TGF-{beta} Type II Receptor and Regulates TGF-{beta} Stimulation of p38 MAPK during Breast Cancer Cell Proliferation and Invasion
Cancer Res., April 15, 2007; 67(8): 3752 - 3758.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
W. Ju, A. Ogawa, J. Heyer, D. Nierhof, L. Yu, R. Kucherlapati, D. A. Shafritz, and E. P. Bottinger
Deletion of Smad2 in Mouse Liver Reveals Novel Functions in Hepatocyte Growth and Differentiation
Mol. Cell. Biol., January 15, 2006; 26(2): 654 - 667.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
M. R. Marques, J. S. Horner, R. A. Ihrie, R. T. Bronson, and L. D. Attardi
Mice Lacking the p53/p63 Target Gene Perp Are Resistant to Papilloma Development
Cancer Res., August 1, 2005; 65(15): 6551 - 6556.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2004 by the American Association for Cancer Research.